Acasti Pharma Co-Founder, Chief Operating and Scientific Officer to Participate on Lipid Panel at the 2019 BTIG Biotechnology Conference

NEXT STORY
Aptevo Therapeutics Reports Second Quarter 2019 Financial Results
PREV STORY
Melinta Therapeutics Names David Gill as Chairman and Announces CEO Succession Plan
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Acasti Pharma Co-Founder, Chief Operating and Scientific Officer to Participate on Lipid Panel at the 2019 BTIG Biotechnology Conference

NEXT STORY
Aptevo Therapeutics Reports Second Quarter 2019 Financial Results
PREV STORY
Melinta Therapeutics Names David Gill as Chairman and Announces CEO Succession Plan
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Qualigen Therapeutics Secures Worldwide Rights to G4-Selective Transcription Inhibitors from University College London to Develop as Cancer Therapeutics

author_avatar
NASDAQ Market News

New Board Members Elected for the International Photodynamic Association

author_avatar
NASDAQ Market News

Cullinan Oncology Announces Management Transition

author_avatar
NASDAQ Market News